Retrophin paid Martin Shkreli 'undisclosed sum' to settle yearslong legal disputes

Remember when Retrophin disclosed in June that it’s finally settled up the four-year legal saga with founder and former CEO Martin Shkreli? In an update for investors on Wednesday, the company added that it had paid an undisclosed sum to the infamous biotech exec and financier as part of the agreement — though it won’t say how much.